Crafting an Effective Clinical-Supply Strategy for the Post-Pandemic Landscape September 18, 2020 Natalie Balanovsky, SCB Contributor The onset of the COVID-19 pandemic brought unprecedented disruption to drug development.Read More
Being Barred from Sales in Canada ‘Worse Than Tariff,’ Says Jack Daniel’s CEOGlobal Trade & Economics